National
Atlas Arteria Urges Shareholders to Reject IFM’s $5.10 Takeover Offer
Atlas Arteria has recommended shareholders reject IFM's $5.10 per security takeover bid, arguing the offer materially undervalues the business. The company said the bid is below the Independent Expert's valuation range and reaffirmed its 2026 distribution guidance of 40.0 cents per security. Atlas Arteria also highlighted potential additional returns from the planned sale of its Chicago Skyway stake, with proceeds expected to be returned to shareholders.
Key Highlights
- Atlas Arteria has urged shareholders to reject IFM's $5.10 per security takeover offer
- The bid had materially undervalued the business, according to the company.
- The bid is 12% under the midpoint
- Atlas Arteria has also reiterated its 2026 distribution guidance of 40.0 cents per security.
- Future asset sales will also have proceeds returned to shareholders on top of normal distributions.
Australia’s Atlas Arteria confirmed that its board today reiterated its recommendation that shareholders reject an unsolicited takeover bid from IFM Investors, with the company's Independent Directors reasoning unanimously that the $5.10 per security offer doesn't reflect full value of the business.
Atlas said the offer came as the business continues to manage its global toll road portfolio and supply value driven initiatives in key phases of growth for Atlas Arteria.
The proposal falls well short of the value of our business and assets, the company said. Atlas Arteria also confirmed its 2026 guidance of an ordinary distribution remaining at 40.0 cents per security. The suggestion follows trailblazing investments that IFM is now bidding on the toll road supplier.
Atlas Arteria: The Offer Undervalues Us
Atlas Arteria said its $5.10 approach is 12% below the midpoint of the Independent Expert's valuation range. The midpoint valuation of $5.79 per security was based on a range of between $5.39 and $6.20 per security, as determined by the Independent Expert;
The valuation backs Atlas Arteria's view that the bid materially undervalues it, particularly with its global toll road portfolio and asset-sale process still in play.
The focus remains on potential returns for shareholders
The company is moving forward on plans to divest a portion or the entirety of its 66.67% stake in the Chicago Skyway, with preliminary agreements expected to be executed in the fourth quarter of 2026.
Atlas Arteria said it would return to shareholders any net proceeds from the Chicago Skyway transaction, along with other asset sales, in addition to its ordinary distribution guidance.
Management also said on taxes tied to the Chicago Skyway sale it was unlikely they would be significant since well thought out and efficient return-of-capital structures are being contemplated.
The company added it remains committed to disciplined management, long-term value creation and sustainable returns for investors by advancing the company's strategic asset review process.
Atlas Arteria share price snapshot: Atlas Arteria shares are down 5% over the past 12 months vs ASX 200: +4%
Atlas Arteria is an infrastructure investment company and a toll road owner/operator with investments in toll road assets across Australia, Europe and North America.
Source: Motley
Follow Inspirepreneur Magazine for daily global business news.